This document summarizes a presentation by Ricardo Baptista Leite on time trends in health for the next decade. It discusses the evolution of healthcare in Portugal, challenges facing the Portuguese national health service like an aging population and non-communicable diseases. It also covers trends toward value-based and patient-centered care, the role of information and communication technologies in areas like precision medicine, and ensuring the financial sustainability of health systems.
World Health Day 2011 aims to raise awareness about antimicrobial resistance (AMR) and promote action to address it. AMR kills annually and jeopardizes healthcare gains. It is a major challenge for treating diseases like tuberculosis, malaria, and gonorrhea as many pathogens are becoming resistant. Weak surveillance systems, poor infection control, and overuse of antibiotics have contributed to the rise of AMR. While strategies exist, more commitment is needed for implementation. World Health Day 2011 will advocate for priority actions and engage stakeholders to strengthen responses to the growing threat of AMR.
World Health Day 2011 aims to raise awareness about antimicrobial resistance (AMR) and promote action to address it. AMR kills annually and jeopardizes healthcare gains. It is a major challenge for treating tuberculosis, malaria, HIV, methicillin-resistant Staphylococcus aureus, and other drug-resistant infections. Weak surveillance systems, inappropriate antibiotic use, and lack of new antibiotics have contributed to the rise of AMR. World Health Day 2011 will advocate for member states to implement comprehensive national plans and collaborate across sectors to combat AMR.
Updates from the CDC - Michael Craig, Senior Advisor for Antibiotic Resistance Coordination and Strategy, National Center for Emerging and Zoonotic Infectious Diseases, CDC, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The purpose of this case study summary is to briefly describe how stakeholders have used the prescriptions dispensed in the community publication to inform analytical, reporting and contract negotiation activities.
This document summarizes a presentation by Ricardo Baptista Leite on time trends in health for the next decade. It discusses the evolution of healthcare in Portugal, challenges facing the Portuguese national health service like an aging population and non-communicable diseases. It also covers trends toward value-based and patient-centered care, the role of information and communication technologies in areas like precision medicine, and ensuring the financial sustainability of health systems.
World Health Day 2011 aims to raise awareness about antimicrobial resistance (AMR) and promote action to address it. AMR kills annually and jeopardizes healthcare gains. It is a major challenge for treating diseases like tuberculosis, malaria, and gonorrhea as many pathogens are becoming resistant. Weak surveillance systems, poor infection control, and overuse of antibiotics have contributed to the rise of AMR. While strategies exist, more commitment is needed for implementation. World Health Day 2011 will advocate for priority actions and engage stakeholders to strengthen responses to the growing threat of AMR.
World Health Day 2011 aims to raise awareness about antimicrobial resistance (AMR) and promote action to address it. AMR kills annually and jeopardizes healthcare gains. It is a major challenge for treating tuberculosis, malaria, HIV, methicillin-resistant Staphylococcus aureus, and other drug-resistant infections. Weak surveillance systems, inappropriate antibiotic use, and lack of new antibiotics have contributed to the rise of AMR. World Health Day 2011 will advocate for member states to implement comprehensive national plans and collaborate across sectors to combat AMR.
Updates from the CDC - Michael Craig, Senior Advisor for Antibiotic Resistance Coordination and Strategy, National Center for Emerging and Zoonotic Infectious Diseases, CDC, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The purpose of this case study summary is to briefly describe how stakeholders have used the prescriptions dispensed in the community publication to inform analytical, reporting and contract negotiation activities.
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The Ministry of Communications and Information Technology is partnering with Apollo Hospitals to launch the SEHAT initiative, which will establish 60,000 centers across India allowing people to consult doctors and order generic drugs online. PM Health and Life Care has launched an online health portal called Zigy.com to connect consumers with chemists for purchasing medicines and medical records. Aurobindo Pharma aims to reach over $3 billion in revenue by 2018 by expanding its drug offerings and product lines. The Andhra Pradesh Department of AYUSH plans to open new hospitals and clinics offering alternative medicine across the state.
Health 2020 is a new European policy framework for health and well-being adopted by the WHO Regional Committee for Europe in 2012. It aims to significantly improve population health and well-being, reduce health inequities, and ensure sustainable health systems. Health 2020 recognizes that health challenges require involvement across all levels of government and society. It provides an adaptable framework for integrated interventions to address major health issues like noncommunicable and communicable diseases.
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
List and links of activities supported by the 2nd Health programme 2008-2013 and the 2rd Health Programme 2014-2020 about chronic diseases, mental health, WHP training, alcohol and immunization.
Prevention of cardiovascular disease: Professor Jamie Waterall, National Lead...NHS England
1) The single largest modifiable risk factor for cardiovascular disease in England is high blood pressure.
2) Every 10 mmHg reduction in systolic blood pressure significantly reduces the risk of major cardiovascular events such as heart disease, stroke, and heart failure.
3) Public Health England is committed to preventing cardiovascular disease through initiatives like their "Getting Serious about CVD Prevention" program, which highlights priorities like engaging over 1 million adults on their heart health and continuing to provide oversight of the NHS Health Check programme.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
A selection of key indicators from "Health at a Glance 2019: OECD Indicators", released on November 7, 2019. More info at http://www.oecd.org/health/health-at-a-glance.htm.
Smart Use of Antibiotics (SUA) in Indonesiamarkovingian
Smart Use of Antibiotics (SUA) in Indonesia
Diberikan dan disampaikan pada Seminar "Cegah Resistensi Antibiotik: Demi Selamatkan Manusia", kerjasama Kemenkes, WHO, dan Yayasan Orang Tua Peduli, didukung oleh React, 5 Agustus 2015
With many more people living longer but developing multiple, complex long-term conditions, it has become more important than ever to ensure health systems are fit for future. So how well are health systems across Europe meeting this challenge?
The document discusses global health challenges and the need to strengthen health systems in low and middle income countries. It argues that defining global health solely in terms of pandemic prevention ignores the importance of universal access to quality health care. Strengthening local health systems through integrated and socially-motivated care delivery is key. The EU is well-positioned to provide technical assistance to support locally-managed health systems and negotiate support for decent public financing of health services.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
The document outlines the opportunities and challenges presented by big data in healthcare. It notes that vast amounts of data are now being generated from sources like genome sequencing, electronic health records, social media, and patient websites. However, simply having large datasets does not guarantee value; the data needs to be analyzed and linked together to generate insights. The document discusses four levels of big data applications from processing large volumes of data to complex modeling. It also examines challenges like developing robust governance, embracing new data uses, overcoming data fragmentation, ensuring data quality and standards, developing innovative analytic methods, addressing skills shortages, and achieving returns on investment. The goal is to improve patient outcomes and healthcare cost-effectiveness through big data.
M&E of HIV/AIDS and Health Programs in Nigeria: Our InnovationsMEASURE Evaluation
Samson Bamidele presented on MEASURE Evaluation's innovations in monitoring and evaluating HIV/AIDS and health programs in Nigeria. Key innovations included establishing a national health data archive, introducing a tool for joint data quality assessments, and strengthening monitoring and evaluation capacity through university partnerships and curriculum reviews. Next steps focused on continuing to build human capacity, conducting impact evaluations, and promoting a culture of data use and evidence-based decision making.
Value Labs Case competition 2018 PPT - Campus FinalistsBhargava Ram
The document provides 15 references to various studies and articles on topics related to corporate wellness programs, healthcare costs, and the use of technology and telemedicine. It also includes a chart on healthcare spending from 1960 to 2016 and definitions of common insurance terminology. In the annexure section, there are additional details on hospital, physician, and prescription drug spending over time.
Additional Domestic Resources to Scale-up the HIV and TB Response in South Af...HFG Project
To tackle its substantial HIV and tuberculosis (TB) burdens, South Africa continues to rapidly scale up its response to both diseases. Over the past decade, the government of South Africa (GoSA) dramatically increased its financing for HIV and TB programs.
Rapid scale-up requires credible resource needs estimates to inform budget allocations. In the spring of 2015, South African officials and experts, in partnership with UNAIDS, finalized the detailed HIV and TB Investment Case that laid out the resource requirements for achieving the country’s coverage goals. Next came the complex task of translating the Investment Case’s findings into recommended budget allocations in South Africa’s Medium Term Expenditure Framework (MTEF), wherein the GoSA determines its budget plans for the next three financial years.
Through intensive engagement in July–September 2015, the USAID/PEPFAR-funded Health Finance and Governance Project (HFG) supported the GoSA National Treasury (NT) in its analysis of HIV and TB budget bids. Each year, NT solicits bids from other national departments for additional funding or to redistribute resources across departmental programs. In this case, the HFG team validated the National Department of Health (NDoH)’s bids against data from the HIV and TB Investment Case and advised both NT and NDoH on how to strengthen the submissions and prioritize investments given general fiscal constraints.
7o Pharma & Health Conference, Δρ. Γεώργιος ΣαρανταυγάςStarttech Ventures
Ομιλία – παρουσίαση: Δρ. Γεώργιος Σαρανταυγάς, Διευθυντής Τμήματος Standards & Solutions, GS1 Association Greece
Τίτλος παρουσίασης: «Βελτίωση της Ασφάλειας Ασθενών & Eξορθολογισμός του Kόστους της Εφοδιαστικής Αλυσίδας της Υγείας μέσω διεθνών προτύπων GS1»
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The Ministry of Communications and Information Technology is partnering with Apollo Hospitals to launch the SEHAT initiative, which will establish 60,000 centers across India allowing people to consult doctors and order generic drugs online. PM Health and Life Care has launched an online health portal called Zigy.com to connect consumers with chemists for purchasing medicines and medical records. Aurobindo Pharma aims to reach over $3 billion in revenue by 2018 by expanding its drug offerings and product lines. The Andhra Pradesh Department of AYUSH plans to open new hospitals and clinics offering alternative medicine across the state.
Health 2020 is a new European policy framework for health and well-being adopted by the WHO Regional Committee for Europe in 2012. It aims to significantly improve population health and well-being, reduce health inequities, and ensure sustainable health systems. Health 2020 recognizes that health challenges require involvement across all levels of government and society. It provides an adaptable framework for integrated interventions to address major health issues like noncommunicable and communicable diseases.
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
List and links of activities supported by the 2nd Health programme 2008-2013 and the 2rd Health Programme 2014-2020 about chronic diseases, mental health, WHP training, alcohol and immunization.
Prevention of cardiovascular disease: Professor Jamie Waterall, National Lead...NHS England
1) The single largest modifiable risk factor for cardiovascular disease in England is high blood pressure.
2) Every 10 mmHg reduction in systolic blood pressure significantly reduces the risk of major cardiovascular events such as heart disease, stroke, and heart failure.
3) Public Health England is committed to preventing cardiovascular disease through initiatives like their "Getting Serious about CVD Prevention" program, which highlights priorities like engaging over 1 million adults on their heart health and continuing to provide oversight of the NHS Health Check programme.
Presented by Piroska Östlin, Director and Åsa Nihlén, Technical Officer, Division of Policy and Governance for Health and Well-being, WHO/Europe, at the 66th session of the WHO Regional Committee for Europe.
A selection of key indicators from "Health at a Glance 2019: OECD Indicators", released on November 7, 2019. More info at http://www.oecd.org/health/health-at-a-glance.htm.
Smart Use of Antibiotics (SUA) in Indonesiamarkovingian
Smart Use of Antibiotics (SUA) in Indonesia
Diberikan dan disampaikan pada Seminar "Cegah Resistensi Antibiotik: Demi Selamatkan Manusia", kerjasama Kemenkes, WHO, dan Yayasan Orang Tua Peduli, didukung oleh React, 5 Agustus 2015
With many more people living longer but developing multiple, complex long-term conditions, it has become more important than ever to ensure health systems are fit for future. So how well are health systems across Europe meeting this challenge?
The document discusses global health challenges and the need to strengthen health systems in low and middle income countries. It argues that defining global health solely in terms of pandemic prevention ignores the importance of universal access to quality health care. Strengthening local health systems through integrated and socially-motivated care delivery is key. The EU is well-positioned to provide technical assistance to support locally-managed health systems and negotiate support for decent public financing of health services.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe (Positioning the Veneto Region at the core of global and European health policies, 3-4 December 2015, Scuola San Giovanni Evangelista, Venice, Italy)
The document outlines the opportunities and challenges presented by big data in healthcare. It notes that vast amounts of data are now being generated from sources like genome sequencing, electronic health records, social media, and patient websites. However, simply having large datasets does not guarantee value; the data needs to be analyzed and linked together to generate insights. The document discusses four levels of big data applications from processing large volumes of data to complex modeling. It also examines challenges like developing robust governance, embracing new data uses, overcoming data fragmentation, ensuring data quality and standards, developing innovative analytic methods, addressing skills shortages, and achieving returns on investment. The goal is to improve patient outcomes and healthcare cost-effectiveness through big data.
M&E of HIV/AIDS and Health Programs in Nigeria: Our InnovationsMEASURE Evaluation
Samson Bamidele presented on MEASURE Evaluation's innovations in monitoring and evaluating HIV/AIDS and health programs in Nigeria. Key innovations included establishing a national health data archive, introducing a tool for joint data quality assessments, and strengthening monitoring and evaluation capacity through university partnerships and curriculum reviews. Next steps focused on continuing to build human capacity, conducting impact evaluations, and promoting a culture of data use and evidence-based decision making.
Value Labs Case competition 2018 PPT - Campus FinalistsBhargava Ram
The document provides 15 references to various studies and articles on topics related to corporate wellness programs, healthcare costs, and the use of technology and telemedicine. It also includes a chart on healthcare spending from 1960 to 2016 and definitions of common insurance terminology. In the annexure section, there are additional details on hospital, physician, and prescription drug spending over time.
Additional Domestic Resources to Scale-up the HIV and TB Response in South Af...HFG Project
To tackle its substantial HIV and tuberculosis (TB) burdens, South Africa continues to rapidly scale up its response to both diseases. Over the past decade, the government of South Africa (GoSA) dramatically increased its financing for HIV and TB programs.
Rapid scale-up requires credible resource needs estimates to inform budget allocations. In the spring of 2015, South African officials and experts, in partnership with UNAIDS, finalized the detailed HIV and TB Investment Case that laid out the resource requirements for achieving the country’s coverage goals. Next came the complex task of translating the Investment Case’s findings into recommended budget allocations in South Africa’s Medium Term Expenditure Framework (MTEF), wherein the GoSA determines its budget plans for the next three financial years.
Through intensive engagement in July–September 2015, the USAID/PEPFAR-funded Health Finance and Governance Project (HFG) supported the GoSA National Treasury (NT) in its analysis of HIV and TB budget bids. Each year, NT solicits bids from other national departments for additional funding or to redistribute resources across departmental programs. In this case, the HFG team validated the National Department of Health (NDoH)’s bids against data from the HIV and TB Investment Case and advised both NT and NDoH on how to strengthen the submissions and prioritize investments given general fiscal constraints.
7o Pharma & Health Conference, Δρ. Γεώργιος ΣαρανταυγάςStarttech Ventures
Ομιλία – παρουσίαση: Δρ. Γεώργιος Σαρανταυγάς, Διευθυντής Τμήματος Standards & Solutions, GS1 Association Greece
Τίτλος παρουσίασης: «Βελτίωση της Ασφάλειας Ασθενών & Eξορθολογισμός του Kόστους της Εφοδιαστικής Αλυσίδας της Υγείας μέσω διεθνών προτύπων GS1»
Ομιλία - Παρουσίαση: Δρ. Νίκος Μανιαδάκης, Καθηγητής & Διευθυντής του Μεταπτυχιακού Προγράμματος Σπουδών & Αναπληρωτής Κοσμήτορας, Εθνική Σχολή Δημόσιας Υγείας.
Ομιλία – παρουσίαση: Αθανάσιος Βοζίκης, Επίκουρος Καθηγητής, Διευθυντής του Εργαστηρίου «Οικονομικών και Διοίκησης της Υγείας», Πανεπιστήμιο Πειραιώς, Τμήμα Οικονομικής Επιστήμης
Τίτλος παρουσίασης: "Η Φαρμακευτική πολιτική στην Ελλάδα (2010-2014): Σε πορεία Ιδιωτικοποίησης και Περιοριστικής Διανομής"
This document discusses Mantri Developers' certifications in quality, environmental, health and safety, and social accountability standards. It is certified in ISO 9001, ISO 14001, OHSAS 18001, and SA 8000. It also provides an overview of the International Organization for Standardization and explains why companies pursue various ISO certifications. The document outlines Mantri Developers' integrated management system documentation structure and policies. It provides information on quality management systems, environmental management systems, and the benefits of each type of system.
The 5-day Integrated Auditor Course teaches employees how to conduct internal assessments of an organization's management system based on integrated standards like ISO 9001, ISO 14001, and OHSAS 18001. The course covers auditing techniques like sampling, interviewing, listening skills, and report writing, with an emphasis on developing corrective action requests. Participants will learn how to plan, execute, record and close out internal audits. Those who complete the course successfully will receive a certificate of attendance and will be able to audit an organization's integrated management systems.
The document describes a health and safety training course called Managing Safely. It is a flexible course lasting a minimum of 24 hours that covers the basics of health and safety management. The course uses innovative and interactive methods like games and videos to engage participants and teach content in a fun way. It is designed for managers and supervisors to learn practical actions for handling health and safety issues in their teams. Successful participants receive an IOSH Managing Safely certificate.
Looking to gain the UK's most popular safety qualification? The NEBOSH National General Certificate is just for you.
Expert tutors, delegate-centred learning, venues across the UK, flexible delivery options and high pass rates make RoSPA the first choice!
The presentation provide a simple and clear explanation to all aspects of ISO : 14001 Environmental Management System for a manufacturing organization with thrust for line managers.
This webinar is a combination of an informative presentation and a Q&A session, with emphasis on preparing for a successful transition. Topics include: status, process and benefits, key concepts and changes, current challenges and opportunities, impact on certification and next steps.
The document provides information about ISO and ISO standards. It discusses:
- ISO is an independent international organization that develops voluntary standards to ensure products/services are safe and of good quality.
- ISO 9001 provides requirements for a quality management system to ensure customer satisfaction. ISO 14001 provides requirements for an environmental management system.
- Certification to the standards by an independent body verifies an organization's management system meets the standard's requirements but certification is not required to implement the standards.
Risk assessment principles and guidelinesHaris Tahir
Risk assessment principles and guidelines is a presentation slides was created and presented at Mission Critical Workshop. This slides is part of Business Continuity Management (BCM) presentation which intended for professional who is responsible for BCM or Risk Assessment Program.
Safety handbook Saudi Aramco BY Muhammad Fahad Ansari 12IEEM14fahadansari131
The document provides guidance on confined space entry permitting procedures. It defines a confined space and outlines the permit process, which includes preparing the space by isolating it, conducting atmospheric testing, providing ventilation and rescue equipment, and restoring the space after entry. Personnel must obtain a Confined Space Entry Permit to enter any confined space to protect them from hazards therein. The permit ensures the space is properly prepared for safe entry and exit.
This document discusses hazard identification, risk assessment, and determining controls. It provides definitions of hazards and risk. It explains that hazard identification and risk assessment should involve identifying hazards, assessing risks, determining controls, implementing controls, and managing change. The document outlines a methodology for teams to identify hazards in their work areas by observing work conditions and tasks and using a risk matrix to rate risks and identify existing and needed controls. The overall aim is to provide a systematic approach to evaluating workplace hazards and risks.
Digitas Health released the results of its research into how European doctors, patients and caregivers use social media for information, education and support. The results were explained at a pharmaceutical marketing conference, ThinkDigital 2010, held by Digitas Health in London on March 25, 2010.
The document discusses the role of diagnostics in preventing antimicrobial resistance (AMR). It notes that inappropriate antibiotic use is fueling the emergence of AMR globally and reducing treatment options. Currently 700,000 deaths per year are due to drug-resistant infections and this could rise to 10 million by 2050. Diagnostics can play a key role in optimizing antibiotic use, preserving new drugs, and enabling surveillance. The document outlines FIND's strategy to develop and promote rapid diagnostic tests to improve rational antibiotic use in low-resource settings and preserve antibiotics by enabling more targeted treatment.
Traditional Medicine Conferences or Traditional Medicine Conferences 2019 will be held in Rome, Italy during July 22-24, 2019 . Alternative medicine conferences, Modern Medical Conferences, Acupuncture conferences, herbal Medicine Conferences is one of the prestigious medicine conferences in Europe, Rome, Italy.
This document provides a summary of a joint research report from the International Alliance of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on biologic medicines. It discusses how biologics have benefited over 350 million patients worldwide by treating illnesses like cancer, heart disease, and arthritis. The report aims to inform patients, health organizations, and policymakers on ensuring optimal, safe, and appropriate access to biologics globally. It explains what biologics are, how they should be regulated and monitored, and how patients can make informed decisions about their use. The document was authored by the Institute for Optimizing Health Outcomes, commissioned by IAPO and
HOPER est une étude qui traite la présence du VIH dans le monde digital. Au cours de 2014, plus de 19 000 documents issus du web et des réseaux sociaux ont été collectés par les outils de LexisNexis Business Informations Solutions. Ils ont ensuite été analysées par ses équipes d'analystes, spécialisés dans le domaine "Life Sciences".
The HOPER report was carried out after collecting more than 19 000 documents throughout the month of March 2014. Then, they were analysed by LexisNexis BIS' Life Sciences analysts.
LEXISNEXIS BUSINESS INFORMATION SOLUTIONS LAUNCHES ISMOR, THE 1ST STUDY ON SOCIAL NETWORKING & DIABETES IN 2013.
Diabetes is a chronic disease for which compliance is a central issue. Complying with the requirements of a strict diet, a regular glucose blood measurements, and medications, requires patients to focus in on their choices and behavior throughout the day. Through ISMOR, LexisNexis Business Information Solutions in partnership with Doctors 2.0 TM & You, will study how Social Media informs us about the use of insulins, including Lantus, Levemir and Humalog.
What practical levers will the study of insulin on Social Media bring?
Do British patient with diabetes use web 2.0 tools in the same way as French patients?
Are patient association forums popular for exchange?
Are patients’ relatives active members of virtual communities?
Do healthcare professionals exchange through these communities?
Do prices or product shortages appear as concerns?
What services or products do patients with diabetes on insulin discuss?
What unmet expectations arise from conversations?
Insulin in Social Media Original Research will result from the collection and analysis of discussions on over 200 social media platforms during February, 2013. 50 of these platforms are diabetes-specific. This study, conducted by LexisNexis Business Information Solutions with commentary from Doctors 2.0 & You, will identify the most discussed topics regarding insulin, including Lantus, Levemir and Humalog.
ISMOR was published at the Doctors 2.0 & You conference on June 6-7, 2013.
LEXISNEXIS BIS LANCE ISMOR, SA 1ERE ETUDE DIABETE & RESEAUX SOCIAUX 2013.
Le diabète est une maladie chronique pour laquelle l’observance est une question centrale. Qu’il s’agisse du régime alimentaire astreignant, des mesures de glycémies régulières ou de l’observance médicamenteuse, le patient diabétique se doit d’être attentif à ses choix et comportements tout au long de la journée.
A travers ISMOR, LexisNexis Business Information Solutions en partenariat avec Doctors 2.0™ & You, va s’intéresser à la manière dont les diabétiques français et britanniques exploitent les réseaux sociaux et échangent autour de l’utilisation des insulines notamment de Lantus, Levemir et Humalog.
Quels leviers de communication autour des insulines vers les médecins, associations de patients, sites spécialisés et bloggeurs?
Les diabétiques britanniques utilisent-ils de la même manière le web 2.0 que les français ?
Les forums de discussion des associations de patients sont-ils des lieux d’échanges prisés ?
Les proches de patients sont-ils des membres actifs des communautés virtuelles ?
Les professionnels de santé échangent-ils à travers ces canaux ?
Le prix ou les ruptures de stocks apparaissent-ils comme des préoccupations ?
Quels autres services ou produits sont discutés par les diabétiques?
Quelles attentes insatisfaites émergent ?
MSD Policy Passport on pharmaceutical innovation - October 2023 v2.pdfBoris Azaïs
Presentation of the key public policies at the source of all medicines ever developed and a review of about 40+ key issues often raised when discussing pharmaceutical policy in a crisp format with references supporting the presentation.
What we’ve learned working with health journalists across Europe by John Lister EvidenceNetwork.ca
John Lister of Coventry University discusses the strengths and pitfalls of foing health and health policy journalism across Europe, and what we can learn in North America.
Presented on behalf of EvidenceNetwork.ca at the University of Manitoba and via webinar on May 14, 2013.
The Centers for Medicare & Medicaid Services outlines their opioid misuse strategy to address the national opioid epidemic. Their strategy includes 4 priority areas: 1) implementing more effective strategies to reduce risks of opioid use disorder, overdoses, and inappropriate prescribing; 2) expanding access to naloxone to reverse overdoses; 3) expanding screening, diagnosis, and treatment of opioid use disorder including medication-assisted treatment; and 4) increasing use of evidence-based practices for pain management. Opioid misuse has led to alarming increases in overdoses and deaths, and CMS aims to combat this through promoting safe opioid use, improving access to treatment, and alternative pain management options.
Four Effective Opioid Interventions for Healthcare LeadersHealth Catalyst
The crisis of opioid abuse in the U.S. is well known. What may not be so well known are the ways for clinicians and healthcare systems to minimize misuse of these addictive drugs. This article describes the risks for patients when they are prescribed opioids and the need for opioid intervention. It offers four approaches that healthcare systems can take to tackle the crisis while still relieving pain and suffering for the patients they serve:
Use data and analytics to inform strategies that reduce opioid availability
Adopt prescription drug monitoring programs to prevent misuse
Adopt evidence-based guidelines
Consider promising state strategies for dealing with prescription opioid overdose
Opioid misuse is a public health epidemic, but treatments are available and it’s time for those involved in the delivery of healthcare to change practices.
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?Jackie Brusch
The Internet of Everything (IoE) is having a major impact across many industries by connecting people, processes and data on a single network. The IoE brings opportunities to make clinical trials more efficient, cost-effective and less intrusive by enabling devices, sensors and applications to connect to healthcare systems via the internet. This allows for remote patient monitoring and the collection of real-time objective data from devices and wearables. The constant flow of rich data allows investigators to remotely manage patients' health, which has potential to speed up drug development times. However, clinical trials have yet to fully embrace the IoE and changes may be needed to regulations and processes to realize the IoE's benefits for research.
This document discusses respiratory diseases and provides information on objectives, how they affect different age groups, relate to communities and families, evidence-based approaches to treatment, health disparities, and resources. The objectives are to identify how respiratory diseases relate throughout the lifespan, improve health through prevention and treatment using research, and identify associated health disparities. It also provides community and online resources for individuals with respiratory diseases.
This document lists sponsors, exhibitors, and speakers for the Orphan Drugs & Rare Diseases Global Congress 2016 Europe conference. It provides an overview of the conference agenda which will focus on key issues impacting the orphan drugs industry such as commercialization, policies, reimbursement, pricing, and more. The two-day conference will provide networking and discussion opportunities between representatives from orphan drug manufacturers, big pharmaceutical companies, biopharmaceuticals, governments, patient groups, and others.
Understanding Physician/ Patient Conversations OnlineW2O Group
MDigitalLife's Managing Director & Founder, Greg Matthews led a webinar discussing the evolution of online interactions between patients and Healthcare Providers (HCPs) and what healthcare companies need to know to stay ahead of the curve.
Pioneering novel approaches to increase access for patients worldwideSandoz
Sandoz aims to pioneer novel approaches to increase access to high-quality healthcare for patients worldwide. In 2015, Sandoz reached 520 million patient lives and their aspiration is to reach one billion. Biosimilars are key to their goal of increasing access, as they can play a transformational role by generating savings for healthcare systems, increasing supply of medicines, and improving patient access to life-saving treatments.
1) Respiratory diseases such as COPD pose a major public health challenge globally and in Moldova.
2) A national strategy is needed to prevent onset and progression through education, limit risk factors like smoking and pollution, and screen at-risk populations.
3) The strategy should also accurately diagnose and treat COPD through quality testing, clinical assessments, and management of comorbidities, while educating patients to self-manage their condition.
What do people think about medicines research and development? (Starling, EUP...Nowgen
The document summarizes findings from a large survey and qualitative research exploring public knowledge and attitudes towards medicines research and development (R&D) in six European countries. Key findings include:
- Low overall knowledge about medicines R&D across countries, ranging from 13-30% knowledgeable.
- Varied levels of trust in different R&D stakeholders between countries.
- Greatest interest in learning more about medicines safety, personalized medicine, and drug discovery.
- Preferred sources of information are doctors, websites, and television.
- Suggested focus areas for public engagement include the R&D process, clinical trials, regulations, and patient roles.
In these slides, I briefly outline how the Internet is changing healthcare by empowering the consumer and the e-patient. We look at data and examples from the USA and Europe, and consider the impact of ratings websites, online health records, and the way in which doctors are responding to the e-patient.
Similar to 7o Pharma & Health Conference, Νίκος Κωστάρας (20)
This document summarizes DEMO Pharmaceutical's investments in biotechnology, including the development and production of monoclonal antibodies. It discusses:
- DEMO's plans to build a new state-of-the-art facility for monoclonal antibody development and production, including a bioacademy, with an investment of 100 million euros over 10 years.
- The manufacturing process for monoclonal antibodies, from cell line development through fill and finish.
- Quality control testing to ensure safety, identity, purity and potency of biologic drugs.
- Biosimilar development which progresses through comparative in vitro and clinical studies to demonstrate similarity to a reference product.
- The impact of DEMO's investments, which will create jobs,
- The document discusses clinical research in pharmaceutical companies, using Bayer as an example.
- It outlines Bayer's focus on disease mechanisms and external collaborations to speed up innovation. This includes partnerships with academia and other industries.
- Bayer has a global drug discovery network and innovation centers that facilitate external collaborations, which are important as about 60% of its clinical programs are advanced through collaborations.
Παναγιώτης Παπαναγιώτου, Αναπληρωτής Καθηγητής Ακτινολογίας, Ιατρικής Σχολής του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών - Καθηγητής Νευροακτινολογίας, Ιατρική Σχολή του Πανεπιστημίου του Saarland, Γερμανία
«Τεχνολογικές εξελίξεις στη διάγνωση και αντιμετώπιση ισχαιμικών εγκεφαλικών επεισοδίων»
Νικόλαος Κουρεντζής, Country Head Radiology-Ελλάδα, Κύπρος, Ισραήλ, Ρουμανία, Βουλγαρία, Μάλτα και Μολδαβία, Bayer
«Οι νέες προκλήσεις στην ιατρική απεικόνιση»
Στέργιος Μπακάλης & Γεώργιος Μπήτρος, 4o Συνέδριο Επαγγελματικής ΑσφάλισηςStarttech Ventures
Ομιλία - Παρουσίαση: «Δημογραφική γήρανση και κοινωνική ασφάλιση στον ορίζοντα του 2050»
Στέργιος Μπακάλης, τ. Καθηγητής στο Πανεπιστήμιο Βικτώρια της Αυστραλίας
Σχολιαστής:
Γεώργιος Μπήτρος, Ομότιμος Καθηγητής Πολιτικής Οικονομίας, Οικονομικό Πανεπιστήμιο Αθηνών
Ομιλία - Παρουσίαση: «GMM Αμοιβαία Κεφάλαια - Το καλύτερο επενδυτικό εργαλείο για Τ.Ε.Α.»
Ηλίας Γεωργουλέας, Ιδρυτής του Ομίλου Global Money Managers Ltd και Διευθύνων Σύμβουλος του Επενδυτικού Ομίλου Global Group SA
The document discusses the economic outlook for Greece and the euro area. It notes that most economic indicators point to relative stagnation in the euro area currently. For Greece, real GDP growth is estimated at 3.6% in 2023, with inflation slowing to 2.5% and unemployment falling further. Several charts show trends in GDP, inflation, fiscal balances, investments and other economic indicators in Greece. EU funding programs like the Recovery and Resilience Facility and the next EU budget will provide around €87 billion for Greece through 2027 to support investments and reforms.
Ομιλία - Παρουσίαση: «Βασικές αρχές για αποτελεσματική Επαγγελματική Ασφάλιση και οι καινοτομίες των Πολύ-εργοδοτικών Ταμείων»
Ανδρέας Χατζηκύρου, Ιδρυτής και Εκτελεστικός Διευθυντής, 7Q Investment Group
Dr. Thorsten Guthke, 4o Συνέδριο Επαγγελματικής ΑσφάλισηςStarttech Ventures
Ομιλία - Παρουσίαση: “Running a multi-employer fund in the EU today: Challenges as we head from the past to the future”
Dr. Thorsten Guthke, Head of European Office, SOKA-BAU HIORP
Ομιλία - Παρουσίαση: «Δημογραφική γήρανση και κοινωνική ασφάλιση στον ορίζοντα του 2050»
Βύρων Κοτζαμάνης, Καθηγητής Δημογραφίας, Επιστημονικός Υπεύθυνος του Ερευνητικού Προγράμματος (ΕΛΙΔΕΚ) "Δημογραφικά Προτάγματα στην Έρευνα και Πρακτική στην Ελλάδα", Πανεπιστήμιο Θεσσαλίας - Επιτροπή Ερευνών / ΕΔΚΑ
Ομιλία - Παρουσίαση: “EU IORP investment governance, lessons learned and future developments”
Tim Currell, Partner, Head of Investment at AON International Wealth
This presentation by OECD, OECD Secretariat, was made during the discussion “Artificial Intelligence, Data and Competition” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/aicomp.
This presentation was uploaded with the author’s consent.
Why Psychological Safety Matters for Software Teams - ACE 2024 - Ben Linders.pdfBen Linders
Psychological safety in teams is important; team members must feel safe and able to communicate and collaborate effectively to deliver value. It’s also necessary to build long-lasting teams since things will happen and relationships will be strained.
But, how safe is a team? How can we determine if there are any factors that make the team unsafe or have an impact on the team’s culture?
In this mini-workshop, we’ll play games for psychological safety and team culture utilizing a deck of coaching cards, The Psychological Safety Cards. We will learn how to use gamification to gain a better understanding of what’s going on in teams. Individuals share what they have learned from working in teams, what has impacted the team’s safety and culture, and what has led to positive change.
Different game formats will be played in groups in parallel. Examples are an ice-breaker to get people talking about psychological safety, a constellation where people take positions about aspects of psychological safety in their team or organization, and collaborative card games where people work together to create an environment that fosters psychological safety.
Mastering the Concepts Tested in the Databricks Certified Data Engineer Assoc...SkillCertProExams
• For a full set of 760+ questions. Go to
https://skillcertpro.com/product/databricks-certified-data-engineer-associate-exam-questions/
• SkillCertPro offers detailed explanations to each question which helps to understand the concepts better.
• It is recommended to score above 85% in SkillCertPro exams before attempting a real exam.
• SkillCertPro updates exam questions every 2 weeks.
• You will get life time access and life time free updates
• SkillCertPro assures 100% pass guarantee in first attempt.
XP 2024 presentation: A New Look to Leadershipsamililja
Presentation slides from XP2024 conference, Bolzano IT. The slides describe a new view to leadership and combines it with anthro-complexity (aka cynefin).
This presentation by Yong Lim, Professor of Economic Law at Seoul National University School of Law, was made during the discussion “Artificial Intelligence, Data and Competition” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/aicomp.
This presentation was uploaded with the author’s consent.
This presentation by Nathaniel Lane, Associate Professor in Economics at Oxford University, was made during the discussion “Pro-competitive Industrial Policy” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/pcip.
This presentation was uploaded with the author’s consent.
This presentation by Thibault Schrepel, Associate Professor of Law at Vrije Universiteit Amsterdam University, was made during the discussion “Artificial Intelligence, Data and Competition” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/aicomp.
This presentation was uploaded with the author’s consent.
Suzanne Lagerweij - Influence Without Power - Why Empathy is Your Best Friend...Suzanne Lagerweij
This is a workshop about communication and collaboration. We will experience how we can analyze the reasons for resistance to change (exercise 1) and practice how to improve our conversation style and be more in control and effective in the way we communicate (exercise 2).
This session will use Dave Gray’s Empathy Mapping, Argyris’ Ladder of Inference and The Four Rs from Agile Conversations (Squirrel and Fredrick).
Abstract:
Let’s talk about powerful conversations! We all know how to lead a constructive conversation, right? Then why is it so difficult to have those conversations with people at work, especially those in powerful positions that show resistance to change?
Learning to control and direct conversations takes understanding and practice.
We can combine our innate empathy with our analytical skills to gain a deeper understanding of complex situations at work. Join this session to learn how to prepare for difficult conversations and how to improve our agile conversations in order to be more influential without power. We will use Dave Gray’s Empathy Mapping, Argyris’ Ladder of Inference and The Four Rs from Agile Conversations (Squirrel and Fredrick).
In the session you will experience how preparing and reflecting on your conversation can help you be more influential at work. You will learn how to communicate more effectively with the people needed to achieve positive change. You will leave with a self-revised version of a difficult conversation and a practical model to use when you get back to work.
Come learn more on how to become a real influencer!
This presentation by Juraj Čorba, Chair of OECD Working Party on Artificial Intelligence Governance (AIGO), was made during the discussion “Artificial Intelligence, Data and Competition” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/aicomp.
This presentation was uploaded with the author’s consent.
This presentation by Professor Alex Robson, Deputy Chair of Australia’s Productivity Commission, was made during the discussion “Competition and Regulation in Professions and Occupations” held at the 77th meeting of the OECD Working Party No. 2 on Competition and Regulation on 10 June 2024. More papers and presentations on the topic can be found at oe.cd/crps.
This presentation was uploaded with the author’s consent.
This presentation by OECD, OECD Secretariat, was made during the discussion “Pro-competitive Industrial Policy” held at the 143rd meeting of the OECD Competition Committee on 12 June 2024. More papers and presentations on the topic can be found at oe.cd/pcip.
This presentation was uploaded with the author’s consent.
This presentation by OECD, OECD Secretariat, was made during the discussion “Competition and Regulation in Professions and Occupations” held at the 77th meeting of the OECD Working Party No. 2 on Competition and Regulation on 10 June 2024. More papers and presentations on the topic can be found at oe.cd/crps.
This presentation was uploaded with the author’s consent.
Competition and Regulation in Professions and Occupations – OECD – June 2024 ...
7o Pharma & Health Conference, Νίκος Κωστάρας
1. 0 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
IMS Health Technology
Enhanced awareness:
Can it help reduce healthcare expenditure?
Insights from Greek internet media usage in Healthcare
7o Pharma & Health Conference
July, 2016 – Athens
Nikos Kostaras, General mgr, IMS Health Greece
2. 1 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
The amount of soda Americans drink has declined
The average number of daily calories has fallen
Physical activity has started to rise
Educated Americans have seen improvements
After decades of relentless
rise, the number of new cases
of diabetes in the United States
has finally started to decline
Higher awareness increases prevention...
3. 2 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Can Digital Media serve this objective?
4. 3 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Research area
Asthma / COPD is a popular area of discussion in the web; Internet
buzz is focused on diagnosis, prevention and treatment
Key Findings:
A great number of specialized sites, many of which
are owned by HCPs create rich and reliable content
Therapeutic approaches are often described and
presented to public
Prevention is an important area including advice on
how to adopt a healthier way of living
Key terms searched:
“Άσθμα”, “ΧΑΠ” and
“χρονια αποφρακτικη
πνευμονοπαθεια”
1,321 distinct links were identified
from 831 distinct domains
Focused on 856 links & 447 domains;
rest were excluded due to minor importance or foreign language
5. 4 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Top websites
Top-20 sites have original content, are better ranked and set the
standards for others
4% of the sites create ~20% of the buzz
pneymonologos.net
www.onmed.gr
respi-gam.net
www.pneumonologia.gr
www.iatropedia.gr
www.iator.gr
blog.doctoranytime.gr
www.pneumon.org
Top 20 HCP domains are very well
ranked and generate 41% of the total
HCP buzz
Among top
websites 18% of the sites belong to HCPs
Among top HCP’s websites
pneymonologos.net
www.pneumonologos.site90.com
www.georgoudakis.gr
e-pneumonologos.gr
www.pneumonologikokentro.gr
6. 5 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Domain’s Theme Content Type
# of Mentions per Domain’s Theme and Content type
Asthma / COPD is mostly mentioned in scientific sites that mainly
post original content
Scientific
40%
1%
News
32%
Blogs
28%
Social Media
5%
Community
33%Copy
Original
62%
7. 6 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Top 20 domains based on Search Engine Ranking
Almost half of the top-20 domains are scientific
9
5
6Blogs
News
Scientific
8. 7 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
% of Mentions per Domain’s different attributes
Most of Asthma / COPD mentions can be found in websites with
focus on health care
Health Focus
62%
1%
17%
0%
Patient Group
20%
PharmaCos News
(general interest)
HCPs
9. 8 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Themes/ Keywords of conversation
Asthma / COPD prevention is the 2nd most common discussion topic
Discussion topics
Disease description Diagnosis
• Scientific disease
description
• Symptoms
• Clinical Description
• Product Characteristics
• Disease diagnosis
techniques
• Keywords:
o Έγκαιρη διάγνωση
o Σπιρομέτρηση
o Λειτουργικός
έλεγχος αναπνοής
Prevention
• Ways to prevent
Asthma/ COPD for
general population
• Keywords:
o Πρόληψη
o Πρόλαβε και
αντιμετωπισε
Treatment
• Holistic treatment using
medicine and way of
living
• Keywords:
o Θεραπεία
o Σωστή διατροφή
o Kάπνισμα
• New products
• Keywords:
o [Company X]
o Καινοτόμα
φάρμακα
16% 21% 36%27%
10. 9 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Indicative comments related to Asthma / COPD
Comments on
Prevention
Comments
on Products
«Ζήσε με υγεία», πρόλαβε και
αντιμετώπισε τη ΧΑΠ»
«3η αιτία θανάτου η ΧΑΠ
μέχρι το 2020»
«Οι Βιταμίνες που βοηθουν
όσους πάσχουν από άσθμα»
«Η ΧΑΠ σκοτώνει, η έγκαιρη διάγνωση
και η στοχευμένη θεραπεία σώζουν»
«PharmaCo 1: Νέα θεραπεία
για άσθμα και ΧΑΠ»
«Καινοτόμος θεραπεία της
PharmaCo 1»
«Η ''ΒΙΤΑΜΙΝΗ ΤΟΥ ΗΛΙΟΥ''
ΘΕΡΑΠΕΙΑ ΓΙΑ ΤΟ ΑΣΘΜΑ»
11. 10 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Key findings
Stakeholders could use the internet to create buzz focused on
diagnosis & prevention aiming to enhance awareness
• People actively use internet to get information & advice
• Web users are interested in diseases prevention: “Prevention” ranked 2nd, right after “Treatment”
and above “Diagnosis” and “Disease description”
• Sites with Original and rich content attarct more users
• In the digital era, it seems there is the opportunity to attract interest and enhance awareness
via added-value, high traffic sites, enhancing awareness creating rich & original content
• COPD attracts the interest of the users, and is ranked above other important diseases
12. 11 IMS Health Confidential Insights from Greek internet media usage in Healthcare • July 2016
Thank you
Connecting you to better healthcare performance